Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01118039
What this trial is testing

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Hospital del Mar 41
Large-scale testing (Phase 3)WithdrawnNCT03693573
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Untreated Locally Advanced or Metastatic Clear Cell or Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Hoffmann-La Roche
Large-scale testing (Phase 3)Study completedNCT00420888
What this trial is testing

ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Active Biotech AB 526
Early research (Phase 1)WithdrawnNCT01441388
What this trial is testing

Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

Who this might be right for
Carcinoma, Renal CellGlioblastomaCarcinoma, Hepatocellular
Pfizer
Testing effectiveness (Phase 2)Study completedNCT01743469
What this trial is testing

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Who this might be right for
Advanced or Metastatic Hepatocellular CancerAdvanced or Metastatic Ovarian CancerMetastatic Renal Cell Cancer+1 more
Ipsen 201
Not applicableWithdrawnNCT01781442
What this trial is testing

A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

Who this might be right for
Renal Cell Carcinoma
Pfizer
Large-scale testing (Phase 3)Study completedNCT00732914
What this trial is testing

Sequential Study to Treat Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sponsor GmbH 272
Testing effectiveness (Phase 2)Looking for participantsNCT07115043
What this trial is testing

Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more
AstraZeneca 120
Early research (Phase 1)Ended earlyNCT00622479
What this trial is testing

Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.

Who this might be right for
Carcinoma, Renal Cell
Bayer 12
Testing effectiveness (Phase 2)Study completedNCT00792025
What this trial is testing

Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Institut Curie 80
Early research (Phase 1)Looking for participantsNCT05759923
What this trial is testing

First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours

Who this might be right for
Advanced Ovarian CarcinomaAdvanced Renal Cell CarcinomaAdvanced Pancreatic Carcinoma+5 more
Molecure S.A. 40
Early research (Phase 1)Study completedNCT02897778
What this trial is testing

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Who this might be right for
NeoplasmsNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type+12 more
Syndax Pharmaceuticals 30
Early research (Phase 1)Ended earlyNCT03809624
What this trial is testing

Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer

Who this might be right for
Metastatic Solid TumorsNon-small Cell Lung CancerMelanoma+6 more
Inhibrx Biosciences, Inc 160
Early research (Phase 1)Looking for participantsNCT07195682
What this trial is testing

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 281
Testing effectiveness (Phase 2)Study completedNCT01141569
What this trial is testing

RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy

Who this might be right for
Clear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00004880
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Jonsson Comprehensive Cancer Center 14
Early research (Phase 1)Study completedNCT00413075
What this trial is testing

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Solid TumorLymphoma
Valerio Therapeutics 121
Early research (Phase 1)Looking for participantsNCT06883539
What this trial is testing

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Who this might be right for
Solid Tumor Malignancies, CancerSolid CancersSolid Tumor Cancer+6 more
LaunXP Biomedical Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT00066612
What this trial is testing

S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
SWOG Cancer Research Network 45
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Next Page